Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study
The purpose of this work was to investigate the distribution pattern of fibrinolytic factors and their inhibitors in rabbit tissues.
The components of the fibrinolytic system in extracts from a variety of rabbit tissues, including tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), plasminogen (Plg), plasmin (Pl) and α2 plasmin inhibitor (α2PI), were determined by colorimetric assay.
The tissue extracts in renal, small intestine, lung, brain and spleen demonstrated strong fibrinolytic function, in which high activity of tPA, Plg and Pl was manifested; whereas in skeletal muscle, tongue and stomach, higher activity of PAI-1 and α2PI showed obviously. Also excellent linear correlations were found between levels of tPA and PAI-1, Pl and α2PI, Plg and Pl. In related tissues, renal cortex and renal marrow showed distinctly higher activity of tPA and lower activity of PAI-1, with the levels of Plg and Pl in renal cortex being higher than those in renal marrow, where the α2PI level was higher than that in renal cortex. Similarly, the levels of tPA, Plg and Pl in small intestine were higher than those in large intestine, but with respect to PAI-1 and α2PI, the matter was reverse. In addition, the fibrinolytic activity in muscle tissue was lower, however, the levels of tPA, Plg, and Pl in cardiac muscle were obviously higher than those in skeletal muscles, and the levels of PAI-1 and α2PI were significantly lower than those in skeletal muscle.
Our data demonstrate that a remarkable difference of the fibrinolytic patterns exists in rabbit tissues, which has probable profound significance in understanding the relationship between the function of haemostasis or thrombosis and the physiologic function in tissues.
Key wordsTissue extract Fibrinolytic factors Fibrinolytic inhibitors
Unable to display preview. Download preview PDF.
- Fang, C.L., Li, Y.P., Lu, X.G., 2005. Experimental study of procoagulant-active substance and its inhibitors in rabbits’ tissues extract. J. Chin. Microcirc., 9(4):267–268 (in Chinese).Google Scholar
- Gesualdo, L., Ranieri, E., Monno, R., Rossiello, M.R., Colucci, M., Semeraro, N., Grandaliano, G., Schena, F.P., Ursi, M., Cerullo, G., 1999. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney Int., 56(2):461–470. [doi:10.1046/j.1523-1755.1999.00578.x]PubMedCrossRefGoogle Scholar
- Hatton, M.W., Southward, S.M., Ross, B.L., Clarke, B.J., Singh, G., Richardson, M., 2006. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors. J. Lab. Clin. Med., 147(1):27–35. [doi:10.1016/j.lab.2005.08.014]PubMedCrossRefGoogle Scholar
- Kurose, I., Miura, S., Suematsu, M., Serizawa, H., Fukumura, D., Asako, H., Hibi, T., Tsuchiya, M., 1992. Tissue-type plasminogen activator of colonic mucosa in ulcerative colitis. Evidence of endothelium-derived fibrinolytic activation. Dig. Dis. Sci., 37(2):307–311. [doi:10.1007/BF01308189]PubMedCrossRefGoogle Scholar
- Lu, X.G., 1990. The Basis and Clinical of Blood Coagulation and Fibrinolysis. Unite Publishing House, Beijing, p.40–42 (in Chinese).Google Scholar
- Lu, X.G., Zhang, G.D., Xu, Y.L., 2003. The investigation of urokinase type and tissue type plasminogen activators in liver cancer tissue extract. Basic Med. Sci. Clin., 23(5):572–573 (in Chinese).Google Scholar
- Sumiyoshi, K., Baba, S., Sakaguchi, S., Urano, T., Takada, Y., Takada, A., 1991. Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb. Res., 63(1):59–71. [doi:10.1016/0049-3848(91)90270-7]PubMedCrossRefGoogle Scholar
- Umeda, T., Eguchi, Y., Okino, K., Kodama, M., Hattori, T., 1997. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues. J. Pathol., 183(4):388–397. [doi:10.1002/(SICI)1096-9896(199712)183:4〈388::AID-PATH943〉3.0.CO;2-I]PubMedCrossRefGoogle Scholar